KOD Kodiak Sciences Inc

Price (delayed)

$114

Market cap

$5.87B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.85

Enterprise value

$5.06B

Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new ...

Highlights
The equity has surged by 152% year-on-year but it has declined by 5% since the previous quarter
Kodiak Sciences's net income has shrunk by 141% YoY and by 19% QoQ
The EPS has plunged by 108% YoY and by 15% from the previous quarter

Key stats

What are the main financial stats of KOD
Market
Shares outstanding
51.45M
Market cap
$5.87B
Enterprise value
$5.06B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.5
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$188.98M
EBITDA
-$180.83M
Free cash flow
-$150.36M
Per share
EPS
-$3.85
Free cash flow per share
-$2.92
Book value per share
$15.2
Revenue per share
$0
TBVPS
$19.34
Balance sheet
Total assets
$997.6M
Total liabilities
$218.17M
Debt
$78.25M
Equity
$779.43M
Working capital
$843.31M
Liquidity
Debt to equity
0.1
Current ratio
21.56
Quick ratio
21.63
Net debt/EBITDA
4.47
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-21.1%
Return on equity
-27.6%
Return on invested capital
-109.3%
Return on capital employed
-19.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KOD stock price

How has the Kodiak Sciences stock price performed over time
Intraday
-1.72%
1 week
2%
1 month
11.76%
1 year
17.98%
YTD
-22.4%
QTD
18.77%

Financial performance

How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$189.97M
Net income
-$189M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has shrunk by 141% YoY and by 19% QoQ
The operating income has plunged by 133% YoY and by 18% from the previous quarter

Growth

What is Kodiak Sciences's growth rate over time

Valuation

What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
7.5
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 108% YoY and by 15% from the previous quarter
The equity has surged by 152% year-on-year but it has declined by 5% since the previous quarter

Efficiency

How efficient is Kodiak Sciences business performance
KOD's ROIC has dropped by 78% year-on-year and by 18% since the previous quarter
The ROA has grown by 12% YoY
KOD's return on equity is up by 8% year-on-year

Dividends

What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOD.

Financial health

How did Kodiak Sciences financials performed over time
The total assets has surged by 132% year-on-year but it has declined by 3.4% since the previous quarter
The total liabilities has surged by 82% year-on-year and by 3.4% since the previous quarter
KOD's debt is 90% lower than its equity
The equity has surged by 152% year-on-year but it has declined by 5% since the previous quarter
KOD's debt to equity is up by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.